Stephen Hoge, President of Moderna, Inc. [MRNA], completed a sale of company stock on 08/12/2024. The transaction involved the disposal of 254 shares of common stock at a price of $84.1047 per share, resulting in a total market value of $21,362.59. This sale followed an acquisition of 522 shares through the exercise or conversion of derivative security on 08/09/2024. After these transactions, Hoge directly holds 1,442,357 shares of Moderna. Additionally, Hoge has indirect ownership of 156,049 shares through entities such as Valhalla, LLC and a Trust.

Stephen Hoge, President of Moderna, Inc. [MRNA], completed a sale of company stock on 08/12/2024. The transaction involved the disposal of 254 shares of common stock at a price of $84.1047 per share, resulting in a total market value of $21,362.59. This sale followed an acquisition of 522 shares through the exercise or conversion of derivative security on 08/09/2024. After these transactions, Hoge directly holds 1,442,357 shares of Moderna. Additionally, Hoge has indirect ownership of 156,049 shares through entities such as Valhalla, LLC and a Trust.